The Mahoney Law Firm, P.C.
search
Call To Schedule A Free Initial Consultation
Phone: 303-800-3168
Practice Area topics

December 2019 Archives

Taking action after experiencing Zinbryta side effects

Zinbryta, otherwise known as daclizumab, was approved by the food and drug administration (FDA) in May 2016 to treat those suffering from relapsing forms of multiple sclerosis (MS). While studies showed that it was effective in reducing the severity of MS relapses in many patients, a wide range of side effects were monitored.

The Mahoney Law Firm
4500 Cherry Creek Dr. S.
Suite 950
Denver, CO 80246

Toll Free: 888-575-4383
Phone: 303-800-3168
Fax: 303-987-0045
Denver Law Office Map

Map